Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

ClinicalTrials.gov ID: NCT01420926

Public ClinicalTrials.gov record NCT01420926. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients >/= 60 Years Old With Acute Myeloid Leukemia (AML)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase II trial studies how well giving decitabine with or without bortezomib works in treating older patients with acute myeloid leukemia. Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of cancer cells, either by killing the cells,by stopping them from dividing, or by stopping them from spreading. Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether decitabine works better when given with or without bortezomib in treating acute myeloid leukemia.

Study identification

NCT ID
NCT01420926
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
165 participants

Conditions and interventions

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 16, 2011 (Actual)
Primary completion
Jun 5, 2016 (Actual)
Completion
Apr 1, 2021 (Actual)
Last update posted
Feb 28, 2023

2011 – 2021

United States locations

U.S. sites
53
U.S. states
21
U.S. cities
44
Facility City State ZIP Site status
Palo Alto Medical Foundation-Camino Division Mountain View California 94040 —
Hartford Hospital Hartford Connecticut 06102 —
Beebe Medical Center Lewes Delaware 19958 —
Christiana Care Health System-Christiana Hospital Newark Delaware 19718 —
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
AdventHealth Orlando Orlando Florida 32803 —
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 —
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201 —
Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne Indiana 46845 —
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242 —
Harold Alfond Center for Cancer Care Augusta Maine 04330 —
Eastern Maine Medical Center Bangor Maine 04401 —
Christiana Care - Union Hospital Elkton Maryland 21921 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
Bronson Battle Creek Battle Creek Michigan 49017 —
Spectrum Health Big Rapids Hospital Big Rapids Michigan 49307 —
Cancer Research Consortium of West Michigan NCORP Grand Rapids Michigan 49503 —
Mercy Health Saint Mary's Grand Rapids Michigan 49503 —
Spectrum Health at Butterworth Campus Grand Rapids Michigan 49503 —
Mercy Health Mercy Campus Muskegon Michigan 49444 —
Spectrum Health Reed City Hospital Reed City Michigan 49677 —
Munson Medical Center Traverse City Michigan 49684 —
University of Missouri - Ellis Fischel Columbia Missouri 65212 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Cooper Hospital University Medical Center Camden New Jersey 08103 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Northwell Health NCORP Lake Success New York 11042 —
Northwell Health/Center for Advanced Medicine Lake Success New York 11042 —
North Shore University Hospital Manhasset New York 11030 —
Long Island Jewish Medical Center New Hyde Park New York 11040 —
Mount Sinai Hospital New York New York 10029 —
NYP/Weill Cornell Medical Center New York New York 10065 —
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 —
Novant Health Presbyterian Medical Center Charlotte North Carolina 28204 —
Wayne Memorial Hospital Goldsboro North Carolina 27534 —
East Carolina University Greenville North Carolina 27834 —
Margaret R Pardee Memorial Hospital Hendersonville North Carolina 28791 —
Vidant Oncology-Kinston Kinston North Carolina 28501 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 —
Cancer Care Associates-Norman Norman Oklahoma 73071 —
Mercy Hospital Oklahoma City Oklahoma City Oklahoma 73120 —
Prisma Health Cancer Institute - Spartanburg Boiling Springs South Carolina 29316 —
Prisma Health Cancer Institute - Butternut Greenville South Carolina 29605 —
Prisma Health Cancer Institute - Faris Greenville South Carolina 29605 —
Prisma Health Greenville Memorial Hospital Greenville South Carolina 29605 —
Prisma Health Cancer Institute - Eastside Greenville South Carolina 29615 —
Prisma Health Cancer Institute - Greer Greer South Carolina 29650 —
Prisma Health Cancer Institute - Seneca Seneca South Carolina 29672 —
Central Vermont Medical Center/National Life Cancer Treatment Berlin Corners Vermont 05602 —
University of Vermont and State Agricultural College Burlington Vermont 05405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01420926, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2023 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01420926 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →